These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34933924)

  • 1. Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses.
    Otunla A; Rees K; Dennison P; Hobbs R; Suklan J; Schofield E; Gunnell J; Mighiu A; Hartmann-Boyce J
    BMJ Evid Based Med; 2022 Oct; 27(5):263-273. PubMed ID: 34933924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
    Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
    Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.
    Shi T; Pan J; Vasileiou E; Robertson C; Sheikh A;
    Lancet Respir Med; 2022 Apr; 10(4):347-354. PubMed ID: 35033224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma and COVID-19 risk: a systematic review and meta-analysis.
    Sunjaya AP; Allida SM; Di Tanna GL; Jenkins CR
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34385278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis.
    Sunjaya AP; Allida SM; Di Tanna GL; Jenkins C
    J Asthma; 2022 May; 59(5):866-879. PubMed ID: 33556287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
    Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
    EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
    Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients.
    Pijls BG; Jolani S; Atherley A; Dijkstra JIR; Franssen GHL; Hendriks S; Yi-Wen Yu E; Zalpuri S; Richters A; Zeegers MP
    F1000Res; 2022; 11():5. PubMed ID: 35514606
    [No Abstract]   [Full Text] [Related]  

  • 10. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
    Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study.
    Shi T; Pan J; Katikireddi SV; McCowan C; Kerr S; Agrawal U; Shah SA; Simpson CR; Ritchie LD; Robertson C; Sheikh A;
    Lancet Respir Med; 2022 Feb; 10(2):191-198. PubMed ID: 34861180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants.
    Irizar P; Pan D; Kapadia D; Bécares L; Sze S; Taylor H; Amele S; Kibuchi E; Divall P; Gray LJ; Nellums LB; Katikireddi SV; Pareek M
    EClinicalMedicine; 2023 Mar; 57():101877. PubMed ID: 36969795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
    Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.
    Fernández Villalobos NV; Ott JJ; Klett-Tammen CJ; Bockey A; Vanella P; Krause G; Lange B
    Syst Rev; 2021 Jun; 10(1):194. PubMed ID: 34193261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.
    Veneti L; Seppälä E; Larsdatter Storm M; Valcarcel Salamanca B; Alnes Buanes E; Aasand N; Naseer U; Bragstad K; Hungnes O; Bøås H; Kvåle R; Golestani K; Feruglio S; Vold L; Nygård K; Whittaker R
    PLoS One; 2021; 16(10):e0258513. PubMed ID: 34634066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis.
    Li Y; Ashcroft T; Chung A; Dighero I; Dozier M; Horne M; McSwiggan E; Shamsuddin A; Nair H
    J Glob Health; 2021 Mar; 11():10001. PubMed ID: 33767855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for exacerbations of asthma.
    Normansell R; Sayer B; Waterson S; Dennett EJ; Del Forno M; Dunleavy A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002741. PubMed ID: 29938789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe.
    Vardavas CI; Mathioudakis AG; Nikitara K; Stamatelopoulos K; Georgiopoulos G; Phalkey R; Leonardi-Bee J; Fernandez E; Carnicer-Pont D; Vestbo J; Semenza JC; Deogan C; Suk JE; Kramarz P; Lamb F; Penttinen P
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36323422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Outcomes Associated With SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis.
    Sumner MW; Kanngiesser A; Lotfali-Khani K; Lodha N; Lorenzetti D; Funk AL; Freedman SB
    Front Pediatr; 2022; 10():916655. PubMed ID: 35757137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.